ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $72 | -20.9% | 14,702 | +0.5% | 0.00% | – |
| Q4 2022 | $91 | -99.9% | 14,625 | +3.8% | 0.00% | -100.0% |
| Q3 2022 | $151,000 | +3.4% | 14,083 | +9.7% | 0.00% | 0.0% |
| Q2 2022 | $146,000 | -60.4% | 12,835 | -68.4% | 0.00% | -50.0% |
| Q1 2022 | $369,000 | -24.1% | 40,589 | +24.3% | 0.00% | 0.0% |
| Q4 2021 | $486,000 | +89.1% | 32,646 | +226.5% | 0.00% | +100.0% |
| Q3 2021 | $257,000 | +233.8% | 10,000 | +227.4% | 0.00% | 0.0% |
| Q4 2020 | $77,000 | – | 3,054 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VV Manager LLC | 1,798,163 | $76,997,000 | 67.53% |
| Wildcat Capital Management, LLC | 1,515,524 | $64,895,000 | 22.42% |
| TPG Group Holdings (SBS) Advisors, Inc. | 19,716,306 | $844,252,000 | 14.91% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 1,279,281 | $54,779,000 | 7.69% |
| Coastal Bridge Advisors, LLC | 463,117 | $19,831,000 | 6.33% |
| DSAM Partners (London) Ltd | 235,098 | $10,067,000 | 2.63% |
| Casdin Capital, LLC | 625,000 | $26,763,000 | 1.58% |
| Alpine Global Management, LLC | 150,000 | $6,423,000 | 1.13% |
| Perceptive Advisors | 1,543,790 | $66,105,000 | 1.07% |
| Avoro Capital Advisors LLC | 1,128,594 | $48,326,000 | 0.96% |